Grimes & Company, Inc. Perkinelmer Inc Transaction History

Grimes & Company, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$119.0 - $147.98 $71,400 - $88,788	-600 Reduced 15.86%	3,182 $0
Q3 2022 Oct 28, 2022	SELL	$118.07 - $160.96 $5,785 - $7,887	-49 Reduced 1.28%	3,782 $455,000
Q2 2022 Jul 22, 2022	SELL	$134.91 - $172.49 $782,882 - $1 Million	-5,803 Reduced 60.23%	3,831 $545,000
Q1 2022 May 06, 2022	SELL	$162.31 - $192.2 $11.7 Million - $13.9 Million	-72,113 Reduced 88.21%	9,634 $1.68 Million
Q4 2021 Feb 01, 2022	BUY	$166.66 - $201.06 $88,829 - $107,164	533 Added 0.66%	81,747 $16.4 Million
Q3 2021 Nov 08, 2021	SELL	$151.98 - $190.5 $3.27 Million - $4.1 Million	-21,519 Reduced 20.95%	81,214 $14.1 Million
Q2 2021 Aug 04, 2021	BUY	$127.81 - $155.84 $109,916 - $134,022	860 Added 0.84%	102,733 $15.9 Million
Q1 2021 May 12, 2021	BUY	$120.35 - $160.53 $12.3 Million - $16.4 Million	101,873 New	101,873 $13.1 Million

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Grimes & Company, Inc. with notifications on news.